Sartorius Investor Relations Material
Latest events
Q3 2024
Sartorius
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Sartorius Aktiengesellschaft
Access all reports
Segment Data
Access more data
Revenue by
Business area
Bioprocess Solutions
Lab Products & Services
Expenses by
Financials
Sartorius Aktiengesellschaft is a global leader in the bioprocess solutions, lab products, and services business. Established as a family business in 1870, Sartorius has long-term experience in development and production at its sites in Germany, Japan, China and the United States. Sartorius is organized into three segments: Bioprocess Solutions, Laboratory Products and Services. Its enterprise-wide approach combined with its commitment to customer satisfaction has enabled Sartorius to provide comprehensive products and services which support the development, qualification and manufacturing of biopharmaceuticals as well as research labs around the world.
Key slides for Sartorius Aktiengesellschaft
CMD 2024
Sartorius Aktiengesellschaft
CMD 2024
Sartorius Aktiengesellschaft
Latest articles
House of Warhammer: The Inner Workings of Games Workshop
A look under the hood of Games Workshop, a high-margin business in an incredibly niche market, with sky-high stock returns.
15 Nov 2024
Crafting a Solid Equity Story: A Strategic Guide for Investor Relations Professionals
Craft a compelling equity story: Align narratives with data to attract ideal investors and build trust with Quartr Pro's powerful IR tools.
13 Nov 2024
Our List of 100 Eminent Serial Acquirers
Serial acquirers have deep experience in mastering value creation through reallocating resources across their portfolio of acquired companies.
12 Nov 2024
Ticker symbol
SRT
Country
🇩🇪 Germany